000 | 01869 a2200517 4500 | ||
---|---|---|---|
005 | 20250517235133.0 | ||
264 | 0 | _c20190520 | |
008 | 201905s 0 0 eng d | ||
022 | _a1557-8194 | ||
024 | 7 |
_a10.1016/j.disamonth.2018.04.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown, Sara A | |
245 | 0 | 0 |
_aCurrent and prospective therapies for acute liver failure. _h[electronic resource] |
260 |
_bDisease-a-month : DM _cDec 2018 |
||
300 |
_a493-522 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBudd-Chiari Syndrome _xcomplications |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xcomplications |
650 | 0 | 4 |
_aDisseminated Intravascular Coagulation _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHELLP Syndrome _xdiagnosis |
650 | 0 | 4 |
_aHepatitis, Viral, Human _xcomplications |
650 | 0 | 4 |
_aHepatocytes _xtransplantation |
650 | 0 | 4 |
_aHepatolenticular Degeneration _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Diseases _xcomplications |
650 | 0 | 4 |
_aLiver Failure, Acute _xdiagnosis |
650 | 0 | 4 |
_aLiver Transplantation _xmethods |
650 | 0 | 4 | _aLiver, Artificial |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 |
_aMushroom Poisoning _xcomplications |
650 | 0 | 4 | _aPhysicians, Primary Care |
650 | 0 | 4 |
_aPlasmapheresis _xmethods |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRespiratory Insufficiency _xcomplications |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aAxenfeld, Ellen | |
700 | 1 | _aStonesifer, Elizabeth G | |
700 | 1 | _aHutson, William | |
700 | 1 | _aHanish, Steven | |
700 | 1 | _aRaufman, Jean-Pierre | |
700 | 1 | _aUrrunaga, Nathalie H | |
773 | 0 |
_tDisease-a-month : DM _gvol. 64 _gno. 12 _gp. 493-522 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.disamonth.2018.04.002 _zAvailable from publisher's website |
999 |
_c28810802 _d28810802 |